XML 23 R8.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Cash Flows
 12 Months Ended
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Cash flows from operating activities:    
Net income (loss) $ 15,022,000 $ (6,405,000)
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Depreciation 1,376,000 1,072,000
Bad debt (recoveries) expense (836,000) 836,000
Impairment of property and equipment 964,000 0
Loss on disposal of property and equipment 0 6,000
Share-based compensation expense 4,273,000 624,000
Change in fair value of SAFE Agreements 2,353,000 91,000
Change in fair value of earn-out liabilities (66,252,000) 0
Change in fair value of warrant liabilities (15,435,000) 0
Loss on issuance of securities 6,729,000 0
Deferred income taxes 7,000 (7,000)
Other 43,000 13,000
Changes in operating assets and liabilities:    
Trade accounts receivable, net (14,743,000) 1,252,000
Contract assets 490,000 (5,135,000)
Prepaid expenses (1,435,000) (5,699,000)
Other assets, net 1,165,000 (2,999,000)
Accounts payable and accrued expenses 14,091,000 3,423,000
Accounts payable – affiliated companies 3,050,000 225,000
Contract liabilities – current and long-term (13,333,000) (1,316,000)
Other liabilities 17,192,000 14,803,000
Net cash (used in) provided by operating activities (45,279,000) 784,000
Cash flows from investing activities:    
Purchase of property and equipment (29,911,000) (16,405,000)
Net cash used in investing activities (29,911,000) (16,405,000)
Cash flows from financing activities:    
Proceeds from Business Combination 8,055,000 0
Proceeds from issuance of Series A Preferred Stock 26,000,000 0
Transaction costs (9,371,000) 0
Proceeds from borrowings 0 7,948,000
Repayment of loans (12,000,000) (108,000)
Proceeds from issuance of securities 20,000,000 6,000
Member distributions (7,952,000) 0
Net costs of stock option exercises (348,000) 0
Forward purchase agreement termination 12,730,000 0
Warrants exercised 16,124,000 0
Investment from non-controlling interests 686,000 0
SAFE Agreements 0 4,250,000
Net cash provided by financing activities 53,924,000 12,096,000
Net decrease in cash, cash equivalents and restricted cash (21,266,000) (3,525,000)
Cash, cash equivalents and restricted cash at beginning of the period 25,826,000 29,351,000
Cash, cash equivalents and restricted cash at end of the period 4,560,000 25,826,000
Less: restricted cash 62,000 62,000
Cash and cash equivalents 4,498,000 25,764,000
Supplemental disclosure of cash flow information    
Cash paid for interest, net 1,919,000 1,013,000
Cash paid for taxes 35,000 0
Accrued capital expenditures 0 (38,000)
Noncash financing activities:    
Transaction costs 15,074,000 0
SAFE Agreements 20,667,000 0
Preferred dividends (2,343,000) 0
Commitment Shares    
Noncash financing activities:    
Class A Common Stock related to CEF (Note 3) 834,000 0
Class C Common Stock    
Noncash financing activities:    
Class A Common Stock related to CEF (Note 3) $ 19,376,000